Patent directory · USPTO A61K / A61P
Browse patents
Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.
Quick answer
NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.
Patent results
-
US 12344596
Solid forms of (S)-1-((2′,6-bis(difluoromethyl)-[2,4′-bipyridin]-5-yl)oxy)-2,4-dimethylpentan-2-amine and salts thereof
granted -
US 12344654
Mage A4 T cell receptors
granted -
US 12345709
CLAUDIN18 antibodies and methods of treating cancer
granted -
US 12344842
Compositions and methods for treating and preventing macular degeneration
granted -
US 12344578
Salt forms of bempedoic acid and methods for using the same
granted -
US 12343432
Encapsulated probiotic
granted -
US 12344665
Treatment of fibrodysplasia ossificans progressiva by administration of an anti-activin a antibody
granted -
US 12344677
Anti-PSMA antibodies, bispecific antigen-binding molecules that bind PSMA and CD3, and uses thereof
granted -
WO 2025133253
EXCIPIENTS DE CONJUGAISON PROTÉINIQUES POUR ADMINISTRATION INTRANUCLÉAIRE
granted -
WO 2025133166
VÉHICULES À BASE DE PROTÉINES POUR CONJUGAISON D'AMINE SPÉCIFIQUE À UN SITE
granted -
WO 2025137347
FORMULATIONS DE RISANKIZUMAB À HAUTE CONCENTRATION
granted -
WO 2025133252
DOMAINES VARIABLES UNIQUES D'IMMUNOGLOBULINE CIBLANT CEACAM5
granted -
WO 2025132620
PRÉPARATIONS DE CAPSULE MOLLE STABLES À REMPLISSAGE SOLIDE POUR PRINCIPES ACTIFS SENSIBLES À L'HUMIDITÉ
granted -
US 12336983
Inhibition of crystal growth of roflumilast
granted -
US 12336995
Combination therapies
granted -
US 12337019
Vehicles for applying bacteria to skin, scalp, and hair
granted -
US 12336985
Methods for shrinking pituitary tumors
granted -
US 12336973
Cancer therapeutic compositions and methods targeting DNAse1L3
granted -
US 12338459
DNA-chimeric antigen receptor T cells for immunotherapy
granted -
US 12336982
Compositions and methods of modulating short-chain dehydrogenase activity
granted -
US 12336980
Dosing regimen for a selective S1P1 receptor agonist
granted -
US 12338269
IL-2 superagonists in combination with anti-PD-1 antibodies
granted -
US 12337020
Bacteriophage compositions
granted -
US 12336835
Neuromodulation to target glucose transporter and/or incretin pathways
granted
Frequently asked questions
What patents are included in this directory?
We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.
How do I search for a patent?
Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.
How is this different from the patent intelligence dashboard?
The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.